US Patent Issued to PRESCIENT MEDICINE HOLDINGS on July 29 for "Development of novel automated screening method for detection of FVIII inhibitors" (Pennsylvania Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,372,540, issued on July 29, was assigned to PRESCIENT MEDICINE HOLDINGS INC. (Hummelston, Pa.).

"Development of novel automated screening method for detection of FVIII inhibitors" was invented by Matthew Stephen Evans (Manheim, Pa.), Keri Jon Donaldson (Hummelstown, Pa.), Mary Elaine Dye (Hershey, Pa.) and Michael H. Creer (Hummelstown, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for determining the presence of a coagulation inhibitor in a patient. A patient curve associated with the patient sample and having a patient slope (Ps) and a a standard curve associated with a control sample and having a control slope (Cs) a...